Oct 22
Earnings call
Q3 2026 earnings call
Galderma Group AG reported record first-nine-month net sales of 4.765 billion U.S. dollars, up 25.1% at constant currency, and raised full-year net sales growth guidance to 22.5 to 23.5%, confirming core EBITDA margin of approximately 26%.